Sachiko Ozawa

Sachiko Ozawa

Associate Professor, Eshelman School of Pharmacy and Adjunct Associate Professor, Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill (Chapel Hill, NC)

June 22, 2021

Sachiko Ozawa, PhD, MHS, is an Associate Professor at the University of North Carolina (UNC) Eshelman School of Pharmacy and an Adjunct Associate Professor in Maternal and Child Health at UNC Gillings School of Global Public Health. She is a health economist whose work focuses on generating evidence that can be used to improve the health of populations globally. Her research focuses on examining the value of vaccines, assessing the economic burden of diseases, and examining the demand and utilization of healthcare. She is interested in the interface between pharmacy and public health from the perspective of a global health economist.

Ozawa’s research has illustrated the economic value of immunizations and demonstrated the importance of ensuring medicines quality globally. Her research on the return on investment from childhood immunizations have been used by the Bill and Melinda Gates Foundation, World Health Organization (WHO), and Gavi (the Vaccine Alliance) to advocate for vaccinations in low- and middle-income countries. Her work modelling the burden of substandard and falsified medicines has contributed to the call to make access to quality medical products a global priority.

Sachiko Ozawa received her MHS and PhD from the Department of International Health at Johns Hopkins Bloomberg School of Public Health. She is trained in health systems and health economics. Prior to joining the UNC Eshelman School of Pharmacy in 2016, she was a faculty member at Johns Hopkins Bloomberg School of Public Health.

She received magna cum laude from the School of Foreign Service at Georgetown University and is a graduate of Phillips Academy, Andover. She is a member of both the Phi Beta Kappa National Honors Society and the Delta Omega Public Health Honors Society.

Role: Panel Member
Report: Fault Lines (2023)